TGF-beta antagonists: why suppress a tumor suppressor?
作者信息
Akhurst Rosemary J
机构信息
University of California-San Francisco, Mount Zion Cancer Research Institute, Room S231, Box 0875, 2340 Sutter Street, San Francisco, California 94143-0875, USA.
出版信息
J Clin Invest. 2002 Jun;109(12):1533-6. doi: 10.1172/JCI15970.
Abstract
摘要
相似文献
1
TGF-beta antagonists: why suppress a tumor suppressor?
J Clin Invest. 2002 Jun;109(12):1533-6. doi: 10.1172/JCI15970.
2
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
J Clin Invest. 2002 Jun;109(12):1607-15. doi: 10.1172/JCI15333.
3
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
J Clin Invest. 2002 Jun;109(12):1551-9. doi: 10.1172/JCI15234.
4
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
Gene Ther. 2013 May;20(5):575-80. doi: 10.1038/gt.2012.75. Epub 2012 Sep 13.
5
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Int J Cancer. 2003 Jul 10;105(5):661-8. doi: 10.1002/ijc.11146.
6
[Construction of a recombinant adenovirus vector harboring human transforming growth factor-beta type II receptor-IgG1Fc fusion gene].
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Dec;28(12):2136-8.
7
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Cancer Res. 2004 Aug 1;64(15):5200-11. doi: 10.1158/0008-5472.CAN-04-0018.
8
Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
Acta Biochim Pol. 2006;53(2):361-9. Epub 2006 May 30.
9
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.
Immunity. 2004 Oct;21(4):491-501. doi: 10.1016/j.immuni.2004.07.020.
10
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Nature. 1996 Sep 12;383(6596):168-72. doi: 10.1038/383168a0.
引用本文的文献
1
Agent-based model demonstrates the impact of nonlinear, complex interactions between cytokinces on muscle regeneration.
Elife. 2024 Jun 3;13:RP91924. doi: 10.7554/eLife.91924.
2
Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment.
Vaccines (Basel). 2023 Sep 7;11(9):1465. doi: 10.3390/vaccines11091465.
3
Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.
J Cell Mol Med. 2023 Sep;27(18):2661-2674. doi: 10.1111/jcmm.17841. Epub 2023 Jul 11.
4
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.
Clin Cancer Res. 2023 Jun 1;29(11):2025-2033. doi: 10.1158/1078-0432.CCR-21-3750.
5
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis.
Pharmaceuticals (Basel). 2022 Nov 29;15(12):1485. doi: 10.3390/ph15121485.
6
TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies.
Cells. 2022 Jul 29;11(15):2336. doi: 10.3390/cells11152336.
7
Fibroblasts Influence the Efficacy, Resistance, and Future Use of Vaccines and Immunotherapy in Cancer Treatment.
Vaccines (Basel). 2021 Jun 10;9(6):634. doi: 10.3390/vaccines9060634.
8
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.
Int J Mol Sci. 2021 May 13;22(10):5150. doi: 10.3390/ijms22105150.
9
Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer.
Front Oncol. 2020 Oct 16;10:568557. doi: 10.3389/fonc.2020.568557. eCollection 2020.
10
Effect of 7,12-Dimethylbenz(α)anthracene on the Expression of miR-330, miR-29a, miR-9-1, miR-9-3 and the mTORC1 Gene in CBA/Ca Mice.
In Vivo. 2020 Sep-Oct;34(5):2337-2343. doi: 10.21873/invivo.12046.
本文引用的文献
1
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
J Clin Invest. 2002 Jun;109(12):1607-15. doi: 10.1172/JCI15333.
2
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
J Clin Invest. 2002 Jun;109(12):1551-9. doi: 10.1172/JCI15234.
3
Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
J Biol Chem. 2002 Jul 5;277(27):24571-8. doi: 10.1074/jbc.M202561200. Epub 2002 Apr 18.
4
The ErbB receptor family: a therapeutic target for cancer.
Trends Mol Med. 2002;8(4 Suppl):S19-26. doi: 10.1016/s1471-4914(02)02306-7.
5
Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
J Cell Biol. 2002 Jan 21;156(2):299-313. doi: 10.1083/jcb.200109037. Epub 2002 Jan 14.
6
TGF-beta signaling: positive and negative effects on tumorigenesis.
Curr Opin Genet Dev. 2002 Feb;12(1):22-9. doi: 10.1016/s0959-437x(01)00259-3.
7
TGF-beta signaling in cancer--a double-edged sword.
Trends Cell Biol. 2001 Nov;11(11):S44-51. doi: 10.1016/s0962-8924(01)02130-4.
8
TGF-beta signaling in tumor suppression and cancer progression.
Nat Genet. 2001 Oct;29(2):117-29. doi: 10.1038/ng1001-117.
9
10
Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.
J Biol Chem. 2001 Oct 19;276(42):38781-6. doi: 10.1074/jbc.M104944200. Epub 2001 Jul 16.
Zotero 插件